This was a randomised trial in @ patients with non-diabetic CKD comparing aliskiren ( @ mg/day ) ( n = @ ) versus losartan ( @ mg/day ) ( n = @ ) and the third group aliskiren ( @ mg/day ) combined with losartan ( @ mg/day ) ( n = @ ) .